Using biomaterials to improve mesenchymal stem cell therapies for chronic, nonhealing wounds
Bioengineering & Translational Medicine · 2024-01 · 9 (1)
DOI: 10.1002/btm2.10598 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 13.09.2023. Verfasst von Romina Keshavarz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering Clarkson University Potsdam New York USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Historically, treatment of chronic, nonhealing wounds has focused on managing symptoms using biomaterial‐based wound dressings, which do not adequately address the underlying clinical issue. Mesenchymal stem cells (MSCs) are a promising cell‐based therapy for the treatment of chronic, nonhealing wounds, yet inherent cellular heterogeneity and susceptibility to death during injection limit their clinical use. Recently, researchers have begun to explore the synergistic effects of combined MSC‐biomaterial therapies, where the biomaterial serves as a scaffold to protect the MSCs and provides physiologically relevant physicochemical cues that can direct MSC immunomodulatory behavior. In this review, we highlight recent progress in this field with a focus on the most commonly used biomaterials, classified based on their source, including natural biomaterials, synthetic biomaterials, and the combination of natural and synthetic biomaterials. We also discuss current challenges regarding the clinical translation of these therapies, as well as a perspective on the future outlook of the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering Clarkson University Potsdam New York USA.
ORCID-Profile: Romina Keshavarz, Sara Olsen, Bethany Almeida
Zitieren
APA
Keshavarz, R., Olsen, S., & Almeida, B. (2024). Using biomaterials to improve mesenchymal stem cell therapies for chronic, nonhealing wounds. Bioengineering & Translational Medicine, 9(1). https://doi.org/10.1002/btm2.10598
Vancouver
Keshavarz R, Olsen S, Almeida B. Using biomaterials to improve mesenchymal stem cell therapies for chronic, nonhealing wounds. Bioengineering & Translational Medicine. 2024;9(1). doi:10.1002/btm2.10598
BibTeX
@article{Keshavarz2024,
author = {Keshavarz, Romina and Olsen, Sara and Almeida, Bethany},
title = {Using biomaterials to improve mesenchymal stem cell therapies for chronic, nonhealing wounds},
journal = {Bioengineering & Translational Medicine},
year = {2024},
volume = {9},
number = {1},
doi = {10.1002/btm2.10598}
}
EUVIMED